To contentTo navigationTo search
Logotype

Implantica presents the third quarter 2020 on November 18, at 10:30 CET

12.11.2020
 | Other press releases

Implantica invites investors to a presentation of the third quarter 2020 at 10:30 a.m. CET on November 18. The interim report for the third quarter will be published at 8:00 a.m. CET on the same day.

The presentation will be in English via a conference call or audio webcast:

Conference call dial-in

  • Sweden: +46850558369
  • United Kingdom: +443333009260
  • United States: +18338230587

Webcast

Speakers

  • CEO Peter Forsell
  • CFO Andreas Öhrnberg
  • VP Operations & IR Nicole Pehrsson
 

For further information, please contact:

Nicole Pehrsson, Investor Relations
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First Premier North Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, +46 (0)8 528 00 399, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on November 12, 2020 at 14:00 CET.

 

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further

Documents

This website uses cookies to provide the best possible user experience. If you continue without making any changes you allow this. Read more about cookies here